medline.ch Onkologie Gynäkologische Tumoren

	Multiomic profiling of ER-positive HER2-negative breast cancer reveals markers associated with metastatic spread. Breast Cancer Res Mosquim Junior S, Zamore M, Vallon-Christersson J, Rydén L, Levander F. PMID: 41526910 [PubMed - as supplied by publisher]
	Identification of novel exosomal miRNAs and their role in diagnosis and prognosis of triple negative breast cancer. BMC Cancer Choudhary A, Poojary SS, Jain P, Chaturvedi H, Das BC. PMID: 41526862 [PubMed - as supplied by publisher]
	Ultrasound for predicting pathological response to neoadjuvant chemotherapy in patients with breast cancer: a systematic review and meta-analysis. BMC Cancer Shi QF, Hu PF, Liu YH. PMID: 41526850 [PubMed - as supplied by publisher]
	Breast cancer survivor's sexual health unmet supportive care needs: a mixed-methods study. J Cancer Surviv Ferreira D, Quinta-Gomes AL, Pieramico S, Weiderpass E, Santana R, Andersson G, Mendes-Santos C. PMID: 41526763 [PubMed - as supplied by publisher]
	Mendelian randomization study of GLP-1R effects on ovarian cancer subtypes mediated by metabolic factors. Commun Med (Lond) Liu J, Chen Z, Yang Q, Lin H, Wang S, Li M, Wang T, Zhao Z, Xu M, Chen Y, Xu Y, Lu J, Gong Q, Ning G, Wang L, Wang W, Bi Y, Zheng J. PMID: 41526703 [PubMed - as supplied by publisher]
	Multidimensional risk impact of obesity on breast cancer incidence, treatment, and prognosis. Int J Obes (Lond) Liu Y, Xu S, Yang H, Wang Y. PMID: 41526462 [PubMed - as supplied by publisher]
	A qualitative study exploring Malaysian women's preferences for authority or emotional appeals in public health messages promoting breast cancer screening. Sci Rep Hing NYL, Kuan PX, Mohamad EMW, Loo CE, Perialathan K, Mohamad Norzlen AN, Yip YY, Zainudin WMS, Abdul Samad S, Mohd Said Z, Hwong WY. PMID: 41526414 [PubMed - in process]
	Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial. BMJ PMID: 41526043 [PubMed - in process]
	Night shift work and breast cancer risk in healthcare workers: a systematic review and meta-analysis. Occup Med (Lond) Esposito G, Bravi F, Santucci C, Zunarelli C, Violante FS, La Vecchia C, Negri E, Turati F. PMID: 41525351 [PubMed - indexed for MEDLINE]
	Metabolic and Hormonal Impact of Subclinical Hypothyroidism in Women with Polycystic Ovary Syndrome: A Cross-Sectional Study from South India. Clin Ter Acharya A, Sulakhe R, Hasamnis VA, Panda A. PMID: 41525122 [PubMed - indexed for MEDLINE]
	Quantitative vs Qualitative analysis of breast lesions on dynamic contrast-enhanced Magnetic Resonance Imaging. Clin Ter Kaur N, Kakkera S, Raj A, Verma M, Sandhu A, Patra A, Singh P. PMID: 41525116 [PubMed - indexed for MEDLINE]
	Genetic Testing for All Breast Cancer Patients: The GET FACTS Randomized Clinical Trial. JAMA Netw Open Weiss A, Braun D, Stopfer J, Zhao J, McGrath M, Bradshaw KR, Rosito MS, Davis D, Garber JE, King TA. PMID: 41525075 [PubMed - indexed for MEDLINE]
	Wnt ligands in breast cancer metastasis: unraveling their dual roles and therapeutic potential. Mol Biol Rep Asadi A, Molavand M, Vaghari-Tabari M, Yousefi B. PMID: 41524847 [PubMed - in process]
	Non-metastatic breast cancer patients discontinuing aromatase inhibitor on denosumab: what next? Osteoporos Int Marcucci G, Biver E, Body JJ, Campusano C, Cannata-Andía J, Confavreux C, de Villiers TJ, Ebeling PR, Hadji P, Kendler D, El Maghraoui A, Napoli N, Veronesi P, Rizzoli R, Brandi ML. PMID: 41524787 [PubMed - as supplied by publisher]
	Screening of metabolic markers related to molecular typing of breast cancer based on 1H NMR metabonomics. Adv Clin Exp Med Xu M, Huang W, Huang X, Shu H, Ke W, Zhang Y, Yang Y. PMID: 41524717 [PubMed - as supplied by publisher]
	Personalizing therapies over the course of hormone receptor-positive/HER2-negative metastatic breast cancer. CA Cancer J Clin Singareeka Raghavendra A, Damodaran S, Barcenas CH, Fuqua SA, Layman RM, Tripathy D. PMID: 41524544 [PubMed - indexed for MEDLINE]
	Evaluation of breast cancer symptoms and risk factors in women: the case of TÃ¼rkiye. Rev Esc Enferm USP Ahi S, Ayata MK, Seyhan M. PMID: 41524420 [PubMed - indexed for MEDLINE]
	Information Needs and Preferences of Men With Breast Cancer: A Qualitative Analysis of Internet Forum Posts. Breast J Schemmel N, Lauberger J, Lühnen J, Steckelberg A. PMID: 41524023 [PubMed - indexed for MEDLINE]
	Diagnostic sensitivity of mammography and magnetic resonance imaging for ductal carcinoma in situ in high-risk breast cancer screening: A systematic-review and meta-analysis. Chin J Cancer Res Li M, Lin Y, Poelhekken K, Greuter MJW, de Bock GH, Dorrius MD. PMID: 41523840 [PubMed]
	A multicenter study of a predictive model for pathological complete response after neoadjuvant therapy in breast cancer using multimodal digital biomarkers. Chin J Cancer Res Yang Z, He J, Li T, Liu C, Wang Y, Ren Y, Zhao W, Chiau CC, Li Q, Xu L, Yue J, Liang T, Jin L, Fang X, Shi B, Shi Z, Yuan P, Gnant M. PMID: 41523834 [PubMed]

Artikel 1 - 20 / 323028

Seite 1 von 16152

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung